AstraZeneca PLC
Saphnelo
systemic lupus erythematosus
Resolved
71days ago
Approval decision · Apr 27, 2026
What's at stake
A final FDA approval decision on Saphnelo for systemic lupus erythematosus is expected Apr 27, 2026.
Primary source
· SEC 6-K
verified 13h ago
“Saphnelo self-administration approved in the US 27 April 2026”